Title : Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapy.

Pub. Date : 2016 Oct 18

PMID : 27611952






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 TP53 status was correlated to response to neoadjuvant anthracycline/taxane-based chemotherapy with or without carboplatin and trastuzumab/lapatinib in HER2-positive and bevacizumab in TNBC. Lapatinib tumor protein p53 Homo sapiens